Tweetovi

Blokirali ste korisnika/cu @XtinaLonergan

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @XtinaLonergan

  1. proslijedio/la je Tweet
    3. velj

    We work to ensure the most promising healthcare innovators can focus on progressing their scientific discoveries. With more than 175 JLABS companies working on potential oncology solutions, together stand up to cancer. More:

    Poništi
  2. 31. sij

    Johnson & Johnson is working with the latest in technology in order to change the trajectory of human health. Join us and help us improve the health across the world, every day. Join Johnson & Johnson as the - Operations Manager - JLABS @ Washington, DC,

    Poništi
  3. proslijedio/la je Tweet
    3. pro 2019.

    Alumnus, , to be acquired by Astellas Pharma for $3B to accelerate the development of genetics medicines for rare neuromuscular diseases.

    Poništi
  4. proslijedio/la je Tweet
    19. stu 2019.

    "One of the key things I learned on my assignment was the importance of understanding the local culture when trying to improve systems and spreading the word about critical programs." -

    , , i još njih 6
    Poništi
  5. 15. stu 2019.

    Johnson & Johnson is working with the latest in technology in order to change the trajectory of human health. Join us and help us improve the health across the world, every day. Join Johnson & Johnson as the - Operations Manager - JLABS @ Washington, DC

    Poništi
  6. proslijedio/la je Tweet
    16. lis 2019.

    ICYMI: Last week announced company, NDR Medical, as the winner of . Start-up company eco. ai was also awarded the & award. Congrats NDR Medical + eco. ai!

    Poništi
  7. 16. lis 2019.

    Congratulations to the JPOD @ Boston Digital Health Technology award recipient – CompanionMx and Clairways! They’ve received residency at + mentoring from to advance their science:

    Poništi
  8. proslijedio/la je Tweet
    9. lis 2019.

    Our site in Belgium was listed in ’s list of The 20 Best Biotech Incubators Hatching Startup Stars in Europe. No-strings-attached ☑️ Modern facilities ☑️ Access to mentorship & education ☑️ Funding resources ☑️

    , , i još njih 4
    Poništi
  9. proslijedio/la je Tweet
    8. lis 2019.
    Poništi
  10. proslijedio/la je Tweet
    7. lis 2019.

    Congratulations to on winning the ! They’ve developed a breakthrough in tissue engineering called “BioPearl technology”. 💪🏽

    , , i još njih 3
    Poništi
  11. proslijedio/la je Tweet
    1. lis 2019.

    : Sharon Chan, Head of , was interviewed by China on the latest and resident company updates. Watch the video interview here & the Chinese/English article on our !

    Poništi
  12. proslijedio/la je Tweet
    2. lis 2019.

    Congratulations to Carcinogenic Exposure awardee on their research collaboration with & ! Learn more about PExA at

    , , i još njih 3
    Poništi
  13. proslijedio/la je Tweet
    25. ruj 2019.

    Great news for resident who announced today that its proprietary AI-based drug discovery platform has identified a novel treatment target &corresponding drug candidate for Wilson disease. News below&view them on

    Poništi
  14. 24. ruj 2019.

    Congratulations resident, Phoenix Molecular Designs who received clearance to enter Phase 1/1b clinical trials for PMD-026 an RSK inhibitor targeting advanced ,read more:

    Poništi
  15. 3. ruj 2019.

    I just scheduled an appointment to donate blood at the Johnson & Johnson blood drive on 2019-09-10. Please consider joining me.

    Poništi
  16. proslijedio/la je Tweet

    is hard at work on tests that look for gene markers that are indicative of . On , learn from our expert researchers about your risk factors—even if you've never smoked—and what you can do to protect yourself:

    Poništi
  17. proslijedio/la je Tweet

    The Lung Cancer Initiative at is powered by a united force and relentless belief that the end of is within our reach. This , learn how J&J is working to change the trajectory of :

    Poništi
  18. proslijedio/la je Tweet

    is proud to continue our pursuit to develop impactful solutions that can help change the story for millions of patients everywhere. On , learn more about the Lung Cancer Initiative at Johnson & Johnson:

    Poništi
  19. proslijedio/la je Tweet
    9. svi 2019.

    Today, announced , Global Head , as Chair of CLSA’s Board. Congrats to you & all new CLSA board appointees. Great leadership driving further momentum in CA's booming life sciences sector!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·